西隴科學(002584.SZ):入選2021年廣東省專精特新中小企業
格隆匯1月7日丨西隴科學(002584.SZ)公佈,公司於2022年1月5日收到廣東省工業和信息化廳文件:粵工信融資函(2021)43號《廣東省工業和信息化廳關於2021年廣東省專精特新中小企業名單的通知》。經地市工業和信息化主管部門審核推薦、專家評審和網上公示,公司入選為2021年廣東省專精特新中小企業,有效期三年:2022年1月-2025年1月。
“專精特新”中小企業是指具備“專業化、精細化、特色化、新穎化”特徵的中小企業,要堅持“以恆心辦恆業”,關注細分市場,聚焦主業,不斷提升創新能力,增強核心競爭力,為實體經濟特別是製造業做實做強做優作出新的更大貢獻。此次入選“專精特新”中小企業是對公司在技術創新、產品服務和發展前景等方面的認可與肯定,有助於提高公司品牌知名度和行業影響力,進一步增強公司的市場競爭力。
公司作為國內技術和規模領先的化學試劑專業製造商和集成供應商,提供優質產品和化學試劑技術解決方案,滿足客户的多樣化需求。公司將堅持“專精特新”主旨,明確目標,聚焦主業,為實體經濟發展作出更大的貢獻。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.